Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab

BACKGROUND: Giant cell tumor of bone (GCTB) is a rare osteoclastogenic stromal tumor. GCTB can rarely undergo malignant transformation. This post hoc analysis evaluated and classified malignancies in patients with GCTB who received denosumab. METHODS: This analysis was conducted on patients with pat...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Palmerini, Emanuela, Seeger, Leanne L., Gambarotti, Marco, Righi, Alberto, Reichardt, Peter, Bukata, Susan, Blay, Jean-Yves, Dai, Tian, Jandial, Danielle, Picci, Piero
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7824947/
https://ncbi.nlm.nih.gov/pubmed/33482769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07739-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items